Welcome to the lead. We're going to start with some breaking news. Just minutes ago, the

U.S. Supreme Board hit pause, pause on the battle in the case of the abortion drug mythopristone.

This means women, girls, doctors can continue to have full access to one of, if not the most

common method of abortion mythopristone without any restrictions, at least for now. The ruling,

decision takes us back to how the situation was in the United States before that Texas judge ruled

in which suspended access theoretically to mythopristone. We're going to start with CNN's Jessica Schneider

and Jessica. This came down just minutes ago. Tell us more about the ruling and this isn't the end

of this fight, right? I mean, the U.S. Supreme Court's going to still make a decision on this.

This is not the end, Jake. That is right. This merely puts this on pause for about five days. I

mean, you can see it's a very short order here. What this does is this is, this is just a Samuel

Alito granting, in part, what the DOJ and FDA was asking for here. They were saying, if you,

if you can't give us anything else, give us an administrative stay, which basically puts a very

brief pause on any of the changes that the fifth circuit had ordered. So what does this mean

practically? Well, this means that full access to mythopristone remains. It remains just like it

did before that Texas judge ruled one week ago, because the concern was that if the Supreme Court

did not do what it just did moments ago, that overnight tonight, 1 a.m. Eastern time, there was

concern that all the rules surrounding this abortion pill mythopristone would have to be changed.

That would mean that doctors would be instructed not to allow women to take this past seven weeks

of pregnancy, because right now it's at 10 weeks of pregnancy. There were also concerns that they'd

make them change the rules about telemedicine and getting this drug in the mail. For now,

none of those rules are changing as was feared, and things will remain the same. However, this is a

very short window of relief for the DOJ and the FDA. The Supreme Court is saying that as of 11.59 p.m.

...